Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling - Nature
Clicks: 191
ID: 272033
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
191 views
39 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #206 of 375 articles by views in Nature
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 375 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease. We proposed that this variability in natural history reflects unrecognized molecular heterogeneity in the tumours. Using DNA microarrays, we have conducted a systematic characterization of gene expression in B-cell malignancies. Here we show that there is diversity in gene expression among the tumours of DLBCL patients, apparently reflecting the variation in tumour proliferation rate, host response and differentiation state of the tumour. We identified two molecularly distinct forms of DLBCL which had gene expression patterns indicative of different stages of B-cell differentiation. One type expressed genes characteristic of germinal centre B cells (‘germinal centre B-like DLBCL’); the second type expressed genes normally induced during in vitro activation of peripheral blood B cells (‘activated B-like DLBCL’). Patients with germinal centre B-like DLBCL had a significantly better overall survival than those with activated B-like DLBCL. The molecular classification of tumours on the basis of gene expression can thus identify previously undetected and clinically significant subtypes of cancer.
| Reference Key |
a.1970naturedistinct
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Alizadeh, Ash A.;Eisen, Michael B.;Davis, R. Eric;Ma, Chi;Lossos, Izidore S.;Rosenwald, Andreas;Boldrick, Jennifer C.;Sabet, Hajeer;Tran, Truc;Yu, Xin;Powell, John I.;Yang, Liming;Marti, Gerald E.;Moore, Troy;Hudson, James;Lu, Lisheng;Lewis, David B.;Tibshirani, Robert;Sherlock, Gavin;Chan, Wing C.;Greiner, Timothy C.;Weisenburger, Dennis D.;Armitage, James O.;Warnke, Roger;Levy, Ronald;Wilson, Wyndham;Grever, Michael R.;Byrd, John C.;Botstein, David;Brown, Patrick O.;Staudt, Louis M.;Alizadeh, Ash A.;Eisen, Michael B.;Davis, R. Eric;Ma, Chi;Lossos, Izidore S.;Rosenwald, Andreas;Boldrick, Jennifer C.;Sabet, Hajeer;Tran, Truc;Yu, Xin;Powell, John I.;Yang, Liming;Marti, Gerald E.;Moore, Troy;Hudson, James;Lu, Lisheng;Lewis, David B.;Tibshirani, Robert;Sherlock, Gavin;Chan, Wing C.;Greiner, Timothy C.;Weisenburger, Dennis D.;Armitage, James O.;Warnke, Roger;Levy, Ronald;Wilson, Wyndham;Grever, Michael R.;Byrd, John C.;Botstein, David;Brown, Patrick O.;Staudt, Louis M.; |
| Journal | Nature |
| Year | 1970 |
| DOI |
doi:10.1038/35000501
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.